Tumor progression is intrinsically tied to the clonal selection of tumor cells with acquired phenotypes allowing to cope with a hostile microenvironment. Hypoxiainducible factors (HIFs) master the transcriptional response to local tissue hypoxia, a hallmark of solid tumors. Here, we report significantly longer patient survival in breast cancer with high levels of HIF-2a. Amphiregulin (AREG) and WNT1-inducible signaling pathway protein-2 (WISP2) expression was strongly HIF2a-dependent and their promoters were particularly responsive to HIF-2a. The endogenous AREG promoter recruited HIF-2a in the absence of a classical HIF-DNA interaction motif, revealing a novel mechanism of gene regulation. Loss of AREG expression in HIF-2a-depleted cells was accompanied by reduced activation of epidermal growth factor (EGF) receptor family members. Apparently opposing results from patient and in vitro data point to an HIF-2a-dependent auto-stimulatory tumor phenotype that, while promoting EGF signaling in cellular models, increased the survival of diagnosed and treated human patients. Our findings suggest a model where HIF2a-mediated autocrine growth signaling in breast cancer sustains a state of cellular self-sufficiency, thereby masking unfavorable microenvironmental growth conditions, limiting adverse selection and improving therapy efficacy. Importantly, HIF-2a/AREG/WISP2-expressing tumors were associated with luminal tumor differentiation, indicative of a better response to classical treatments. Shifting the HIF-1/2a balance toward an HIF-2-dominated phenotype could thus offer a novel approach in breast cancer therapy.
Introduction
A mismatch between metabolic demand and oxygen delivery leads to local hypoxia and cellular energy crisis in solid tumors. Hypoxia-inducible factors (HIFs) mediate the transcriptional adaptation of hypoxic cells to these microenvironmental conditions (Bertout et al., 2008) . HIFs are composed of constitutively expressed b-subunits and one out of two oxygen-labile a-isoforms, resulting in transcriptionally active HIF-1 and HIF-2 heterodimers, respectively. Although structurally highly similar, specific roles of HIF-a isoforms in tumorigenesis have been defined Semenza, 2010) . Pioneering work using genetically modified mouse embryonic fibroblast with targeted disruption of both Hif1a alleles suggested a predominant role of HIF-1a for regulating gene expression in response to hypoxia (Park et al., 2003) , a finding that was confirmed for a limited number of classical HIF target genes in human cell lines by using transient RNA interference against both HIF-a isoforms (Sowter et al., 2003) . However, expression analyses in a renal clear cell carcinoma-derived cell line deficient for HIF-1a revealed preserved hypoxic induction of many known HIF target genes, indicating that effectively both HIF-a isoforms contribute to hypoxia-induced transcription (Hu et al., 2003) . Domain-swapping experiments between HIF-1a and HIF-2a provided experimental evidence for the interchangeability of the DNA-binding regions of either isoform and attributed gene selectivity to the N-terminal transactivation domains of HIF-a Lau et al., 2007) .
Interestingly, ongoing hypoxia in a variety of human cancer cell lines leads to a specific downregulation of HIF-1a whereas HIF-2a protein levels rather increase, suggesting adaptive activation of the hypoxia-responsive pathway during acute and chronic tissue hypoxia (Holmquist-Mengelbier et al., 2006; Stiehl et al., 2006) . A transient activation of HIF-1 could also be observed in growing tumors in vivo by using an allografted murine tumor model (Lehmann et al., 2009) . As a consequence of the low structural order of neoplastic tissues and given the enormous plasticity of the tumor-sustaining vasculature, spatial and temporal tumor oxygenation is highly variable (Dewhirst et al., 2008; Lehmann et al., 2009 ). Thus, acute temporal fluctuations in tumor oxygenation might preferentially induce HIF-1, whereas chronically hypoxic tumor areas would be marked by enhanced HIF-2 levels. To study the transcriptional ramifications of distinct accumulation tendencies of HIF-a isoforms under acutely and chronically hypoxic conditions, we stably downregulated HIF-1a and/or HIF-2a by short-hairpin RNA interference in a cellular model of hormone-sensitive breast cancer.
Results
HIF-1a dominates the acute response to hypoxia by suppressing HIF2A gene expression HIF-1a protein levels in parental MCF-7 cells cultured for up to 72 h at 1% oxygen were maximally induced after 4 h of hypoxic exposure and constantly declined during prolonged hypoxia, whereas HIF-2a levels showed delayed induction kinetics, with peak levels observed after 24-48 h (Figures 1a-c) . Cell lines depleted of HIF-1a (shHIF1A #16, 21 and 24, respectively) had strikingly increased HIF-2a levels compared with the parental cell pool and HIF-2a protein was steadily increasing under chronic hypoxia (Figure 1a) . A similar increase in HIF-2a transcript levels under prolonged hypoxia was observed only in the absence of HIF-1a ( Figure 1d , lower panel), indicating mutual exclusion of both isoforms, with a dominant role of HIF-1a suppressing HIF2A/EPAS1 gene expression. In line with such a hierarchical model, stable knockdown of HIF-2a expression in three independent cell pools (shHIF2A #1, 4 and 5) had only minor effects on the remaining HIF-1a isoform, with slightly increased protein levels under prolonged hypoxia (Figure 1b) . Observations of cross-regulation among HIF-a isoforms have been reported previously in renal cell carcinoma lines (Raval et al., 2005) . The drastic decrease in HIF-1a transcript levels observed in response to acute hypoxia Figure 1 Reciprocal induction kinetics of HIF-a isoforms: early HIF-1a and late HIF-2a. (a) MCF-7 (parental) and the respective shHIF1A clones (#16, 21 and 24), or (b) three independent stable cell pools, lentivirally infected with different targeting sequences for HIF2A, were subjected to 1% oxygen for up to 72 h and whole-cell protein extracts were immunoblotted for the proteins indicated. (c) Combined knockdown of both HIF-a isoforms was achieved by infecting clone shHIF1A #24 with pLKO.1-hygro shHIF2A #4. Extracts were analyzed as above. (d) Transcript levels derived from parental, shHIF1A, shHIF2A and shH1A/H2A cultures were quantified by reverse transcription-quantitative PCR (RT-qPCR). Control cells ('C') were cultured at 20% oxygen, whereas hypoxic ('hyp') probes were sampled at the same time points as shown in the immunoblots. All data are shown as the mean ± s.e.m. of three independent experiments and normalized to ribosomal protein L28 mRNA levels. The highest hypoxic mRNA levels in the parental cell line were arbitrarily defined as 1 in each independent experiment. (e) Immunoblot analyses of parental MCF-7 cells cultured at 20% oxygen and exposed to 1 mM dimethyloxalylglycine (DMOG) as indicated. DMOG was re-added after 24 h for the latest time point to ensure continuous PHD inhibition. Cells cultured at 1% oxygen for 24 h served as positive control.
HIF-2a is associated with luminal breast cancer DP Stiehl et al (8 h) did not affect the protein levels at the same sampling time (Figures 1b and d, upper panel) , suggesting at least partially independent regulation on the mRNA and protein levels. Among the HIF target genes, hypoxically induced HIF prolyl-4-hydroxylases PHD2 and PHD3, as well as the regulator of protein translation REDD1, have been implicated in regulating HIF-a protein expression under hypoxic conditions (Brugarolas et al., 2004; Stiehl et al., 2006; Minamishima et al., 2009) . Whereas basal levels of PHD2 remained unaffected in both HIF-a-knockdown models, hypoxic induction of PHD2 was abolished specifically in the absence of HIF-1a (Figures 1a and b) . Notably, the knockdown efficiency for all HIF-a cell lines and pools was 480% and HIF-1a knockdown proved sufficient to abrogate the expression of carbonic anhydrase-9 (CA9), another well-characterized HIF target gene (Wykoff et al., 2000) (Figures 1a and d) . Both PHD3 and REDD1 hypoxic expression kinetics were markedly delayed in the absence of HIF-1a, but only PHD3 showed 2-to 3-fold increased hypoxic protein accumulation in shHIF2A cell pools (Figures 1a and b) . To test whether the residual hypoxic induction of PHD3 and REDD1 was caused by redundancy of HIF-a isoforms, a double knockdown of both HIF-a isoforms was generated. As shown in Figure 1c , hypoxic induction of PHD3 was fully lost in the shH1A/H2A double knockdown pools and REDD1 was only marginally induced by hypoxia, confirming that the delayed hypoxic response observed for both proteins in the shHIF1A clones indeed was mediated by HIF-2. Interestingly, normoxic induction of HIF-a isoforms as achieved by continuous inhibition of prolyl-hydroxylation by using dimethyloxalylglycine followed the same temporally staggered pattern as observed under chronic hypoxic conditions, suggesting that the HIF pathway self-sufficiently controls the distinct stabilization kinetics of the two HIF-a subunits (Figure 1e ).
HIF-a isoforms determine target gene kinetics rather than specificity Prompted by the variability of the hypoxic response and the target specificity of the HIF-a isoforms, we were interested in testing whether our model cell lines would prove useful to identify novel profiles of co-regulated genes in a setting of acute and chronic hypoxia. The temporal gene expression patterns of 34 known HIF target genes (Aprelikova et al., 2006; Elvidge et al., 2006) were analyzed for HIF-1 and HIF-2 dependency by quantitative PCR in cells exposed to 1% oxygen for 4-72 h. Unbiased grouping of putatively related hypoxic gene expression profiles by K-means clustering resulted in four distinct groups with 8-10 set members (Figure 2a) . The mean hypoxic expression profiles from all members in one group showed surprisingly low variability, implying the existence of common regulatory mechanisms of hypoxic gene activation (see red curves in Figures 2b-e, representing log 2 ratios of relative gene expression levels). As reported previously, the large majority of genes (for example, glycolytic enzymes and genes involved in metabolic adaptation to low oxygen availability) were predominantly depending on HIF-1a (Semenza et al., 1994; Iyer et al., 1998; Hu et al., 2003) . Genes in Group-1 essentially required HIF-1a for gene transcription (Figure 2b ). Among these, CA9 and PPFIA4 showed strikingly high hypoxic induction factors, highlighting their putative value as hypoxia marker genes. Group-2 encompassed target genes such as PHD3 with delayed hypoxic induction in the absence of HIF-1a and loss of hypoxic induction when both HIF-a isoforms were ablated, suggesting that these genes are required in both acute and chronic hypoxia (Figure 2c ). Rather unexpectedly, Group-3 genes, including classical HIF target genes such as vascular endothelial growth factor (VEGF) and glucose transporter-1 (GLUT1), were only marginally affected by depletion of one HIF-a isoform and were still robustly induced by hypoxia even when both HIF-a isoforms were suppressed ( Figure 2d ). As our MCF-7 model used an RNA interference-mediated knockdown strategy, loss of HIF-a expression is incomplete and residual hypoxic induction of target genes clustering in Group-3 might be caused by the remaining HIF activity. Interestingly, HIF-1a has been found to form surprisingly stable complexes with the VEGF promoter with a half-life of more than 1 h (Yu and Kodadek, 2007) . While it is unclear how these findings relate to the dynamics of promoter-bound HIFs in general, one might suspect that certain promoter environments stabilize DNA-bound HIFs more efficiently than others and thus still strongly respond to hypoxia if only low levels of HIFs are present. Alternatively, other hypoxiaresponsive transcription factors (reviewed by Cummins and Taylor, 2005 ) might contribute to residual hypoxic gene induction in shH1A/H2A MCF-7 cells.
Only few genes were identified, which showed selective activation by HIF-2. All genes downregulated in the absence of HIF-2a were only modestly induced by hypoxia in parental cells, but were strikingly superinduced at late time points in the absence of HIF-1a ( Figure 2e ). As this observation could reflect the robust hypoxic induction of HIF-2a mRNA and protein in shHIF1A cell lines, we re-analyzed the data with specific focus on genes with highest expression levels under these conditions: surprisingly, mRNA levels of IGFBP3, LOXL2 and EGFR followed a similar expression profile, with pronounced hypoxic induction in shHIF1A cells, although the transcript levels of these genes were only mildly affected by knockdown of HIF-2a (Supplementary Figure S1 ).
HIF-2a/AREG/WISP2 defines a positive prognostic axis in human breast cancer To study the selective role of HIF-a isoforms in breast tumorigenesis, tissue microarrays of tumor samples derived from 282 breast cancer patients with primary mammary carcinoma were stained for HIF-1a and HIF-2a. The antibodies used for immunohistochemical staining of paraffin-embedded tissue sections were validated for target specificity on a test array composed HIF-2a is associated with luminal breast cancer DP Stiehl et al of equally fixed and embedded cell pellets from respective HIF-a-knockdown cell lines (Supplementary Figure S2) . While the overall survival of patient cohorts with low versus high nuclear expression of HIF-1a in neoplastic cells did not differ, patients with HIF-2a-expressing tumors lived significantly longer (Po0.01, log rank test) than those with tumors expressing little or no HIF-2a ( Figure 3a ). In line with this observation, HIF-2a expression levels in tumors correlated with low tumor grading (Po0.01, Spearman's r.), whereas in Figure 2 HIF target genes cluster with distinct hypoxic expression profiles. (a) Transcript levels determined by reverse transcriptionquantitative PCR for known HIF target genes in parental, shHIF1, shHIF2 and double-knockdown shH1A/H2A MCF-7 cells exposed to 1% oxygen for up to 72 h. The heatmap illustrates the time-resolved hypoxic expression kinetics for each gene with a dynamical range from À3 (lowest expression) to þ 3 (highest expression) in blue and red, respectively. The data represent log 2 (ratios) of the mean of three independent experiments normalized to L28 mRNA levels. Genes were grouped by time-resolved gene expression by applying K-means clustering. (b-e) Hypoxic gene expression profiles of each group shown as mean induction (log 2 ratios) of all group members (red line and right y-axes). The gray-shaded areas indicate the dynamic range of the hypoxic response in parental cells. Group-1 and Group-4 have been further sub-grouped, as individual genes showed particularly high hypoxic induction factors. A representative gene of each group is also shown (bar graphs relate to left y-axes, mean±s.e.m.). HIF-2a is associated with luminal breast cancer DP Stiehl et al cases with high expression levels of HIF-1a, a significant association (Po0.01, Spearman's r) with disseminated decay of lymph nodes was observed (Figure 3b,  left table) . Given the low number of selectively HIF-2a-regulated target genes found in MCF-7 cells, tissue microarrays were further stained for inositol-1,4,5-triphosphate receptor type-1 (ITPR1), plasminogen activator inhibitor-1 (PAI1), Wnt-1-inducible signaling pathway protein-2 (WISP2) and amphiregulin (AREG), an epidermal growth factor (EGF) family member which we recently identified to be strongly downregulated in MCF-7 cells lacking HIF-2a (Bordoli et al., 2011) .
Immunohistochemical analyses of CA9 and GLUT1
HIF-2a is associated with luminal breast cancer DP Stiehl et al were included as established histological markers of tissue hypoxia (Wykoff et al., 2000; Tomes et al., 2003) . Rank order correlations confirmed that AREG and WISP2 were significantly more abundant in tumors also positive for HIF-2a, with correlation coefficients of 0.442 (Po0.01; n ¼ 192) and 0.264 (Po0.01; n ¼ 192), whereas PAI1 and CA9 showed no specific association with one particular HIF-a isoform, although both PAI1 and CA9 significantly correlated with HIF-a expression in general. No correlation was observed between ITPR1 and HIF-a expression levels. Uniquely among the proteins tested, GLUT1 and WISP2 levels reciprocally correlated with HIF-a isoforms, indicating that these factors might be useful as downstream markers to discriminate the dominant HIF-a isoform in breast cancers (Figure 3b, right panel) .
Kaplan-Meier survival curves of patient subgroups whose tumors expressed both AREG and WISP2 at high levels revealed a significantly improved survival time (Po0.01, log rank test) when compared with cohorts expressing only one or none of these two growth factors (Figures 3c and d) . To test for a putative relation between expression of HIF-2a, AREG and WISP2, we examined the co-aggregation of either parameter in patients where all three factors could be assessed (n ¼ 192). In the large majority (76-84%) of cases, aggregation with at least one other factor was observed and a substantial fraction (35-43%) was positive for all three features. Remarkably, exclusive expression of HIF-2a, AREG or WISP2 alone was rare and ranged from 9 to 16% of all cases only (Figure 3e ).
The WISP2 and AREG promoters are predominantly activated by HIF-2a Motivated by clinical evidence for a relation between HIF-2a, AREG and WISP2 expression, and the putative prospective value of all three proteins, we set out to investigate the molecular mechanisms underlying co-regulation of both growth factors. Whereas hypoxic regulation of endogenous WISP2 transcript levels at least partially involved also HIF-1a, AREG mRNA was non-responsive to oxygen deprivation and basal levels were strikingly downregulated in both shHIF2A-and HIF-a double-knockdown MCF-7 pools (Figure 4a ).
Re-expression of short-hairpin-insensitive HIF-2a in MCF-7 shHIF2A led to a dose-dependent induction of WISP2 and AREG promoter activities, whereas only minor or no such effects were observed when cells were transfected with equal amounts of an HIF-1a expression plasmid (Figure 4b ). We previously mapped the minimal HIF-2a-responsive region of the human AREG promoter (Bordoli et al., 2011) . Surprisingly, this region encompassing 120 nucleotides in both directions of the transcriptional start site (Figure 4c , upper panel) does not contain the consensus HIF-binding site 5 0 -RCGTG-3 0 (Wenger et al., 2005) . Deletion of a major part of the AREG 5 0 -untranslated region (UTR) completely abolished the co-activating effect of HIF-2a overexpression whereas basal AREG promoter activity was retained, suggesting an essential role of the 5 0 -UTR in regulating AREG transcription (Figure 4c , lower panel). The luciferase reporter gene construct pGL(P2P) driven by the human PHD2 promoter demonstrated functional activity of exogenous HIF-1a expression and served as a hypoxic control. However, the isolated AREG 5 0 -UTR failed to confer HIF-2a responsiveness to the heterologous reporter gene construct pGL3prom, driven by the SV40 minimal promoter, whereas the HIF-dependent enhancer element derived from the human PHD2 promoter in the same context readily responded to hypoxia and HIF-1a overexpression (Figure 4d ).
Endogenous HIF-2a is recruited to the minimal AREG promoter As HIF-2a regulation of the AREG promoter could not be attributed to the canonical HIF pathway (lack of hypoxic inducibility, absence of a functional HIFbinding site), phylogenetic footprint analyses were applied to identify other conserved regulatory elements in the minimal HIF-2a-responsive region. Genomic sequences of AREG orthologs derived from 15 mammalian species were subjected to multiple sequence alignments, highlighting four elements of at least 3-bp length with sequence similarities of 490% (Figure 5a , black boxes). Confirming our approach, two of these sites comprised experimentally described functional Wilms' tumor suppressor-1 (WT-1) and cAMP-response element-binding protein (CREB)-responsive elements (WRE and CRE, respectively) in the AREG promoter (Lee et al., 1999) . In addition, conserved E-box (5 0 -CAGGTG-3 0 ) and T-box (5 0 -CACACCT-3 0 ) elements were identified (Figure 5a) . Disruption of the WRE (DWRE) as well as two truncations of the AREG 5 0 -UTR (pAREG-DSacI and pAREG-DSmaI) significantly attenuated the specific responsiveness of the respective reporter constructs to HIF-2a (Figure 5b ). Although mutation of the CRE site (DCRE) reduced basal AREG promoter activity by 75% as expected (data not shown), induction by HIF-2a was fully preserved. Mutation of the putative E-box (DE-box) and T-box (DT-box) motifs neither affected the basal reporter activity nor the response to forced expression of HIF-a (Figure 5b ).
Chromatin immunoprecipitation (ChIP) of parental MCF-7 cultures using HIF-a isoform-specific antibodies confirmed the presence of endogenous HIF-2a at the minimal AREG promoter (Figure 5c) . Surprisingly, the same promoter region was also enriched to some extent in ChIP experiments performed using anti-HIF-1a antibodies, despite complete absence of any functional response of the AREG promoter to this particular isoform. Yet, the HIF-1a-dependent enrichment factors of the AREG promoter chromatin were B30 times lower than those observed for the hypoxia response element (HRE)-containing promoter region of the BHLHB2 gene, whereas enrichment by HIF-2a precipitation was roughly comparable between both promoters (Figure 5c ). Notably, endogenous BHLHB2 expression levels were to a similar extent dependent on HIF-1a and HIF-2a (Supplementary Figure S3) . Thus, differences in promoter occupation by HIF-a isoforms as observed in ChIP experiments might be at least partially explained by the low efficiency of HIF-2a precipitation.
HIF-2a DNA-binding and activation domains are essential for AREG and WISP2 promoter induction Previous work on HIF-a selectivity indicated a role of the N-terminal activation domain in controlling specific 0 -UTR is not sufficient to mediate activation by HIF-2a. The SV40 minimal promoterdriven luciferase fused to the AREG 5 0 -UTR was co-transfected with HIF-a expression plasmids or an empty vector and luciferase activity was measured as described above. The UTR-lacking plasmid (pGL3prom) and the hypoxia-responsive reporter pSVL(P2P) (95bp) served as controls. Representative experiments performed in triplicates (mean ± s.e.m.) are shown.
HIF-2a is associated with luminal breast cancer DP Stiehl et al target genes Lau et al., 2007) , further supported by the fact that the DNA-binding basic helixloop-helix as well as the Per-ARNT-Sim domains are 487% conserved between both transcription factors. We constructed HIF-1a/HIF-2a hybrid expression plasmids (designated H1a/H2a and H2a/H1a, respectively) with interchanged basic helix-loop-helix and Per-ARNT-Sim portions as schematically depicted in Figure 5d . Unexpectedly, both hybrid HIF-a proteins failed to activate either the AREG or the WISP2 promoters (Figures 5e and f) , although they maintain isoform specificity for the PHD2 promoter ( Figure 5g ) and isoform independency for an artificial HIF reporter gene (pH3SVL; Figure 5h) . Thus, the AREG and WISP2 promoters may indeed define a novel class of HIF-2a-regulated genes whose activation mechanism requires full integrity of the HIF-2a protein and thus differs from the canonical HIF pathway. Figures  S4a and b) . Supporting this hypothesis, stimulation of HIF-2a-knockdown pools with recombinant AREG particularly activated EGF and ErbB4 receptors, which were both hypo-phosphorylated in the absence of HIF2a (Figure 6b ). No receptor activation was observed in serum-starved cells similarly stimulated with recombinant WISP2 (data not shown). While our work was in progress, another study reported similarly reduced EGFR phosphorylation in human glioma, lung and colon carcinoma cell lines depleted of HIF-2a, postulating a widespread mechanism of HIF-2a-mediated growth control in human cancers (Franovic et al., 2009) . In line with this study, we found reduced bromodeoxyuridine incorporation in shHIF2A cells when compared with parental MCF-7 cultures under both normoxic and hypoxic conditions (Supplementary Figure S4c) . Cellular proliferation was also affected by HIF-1a knockdown, indicating that the crosstalk between HIF signaling, cellular growth pathways and cell-cycle control is complex.
HIF-a isoforms are reciprocally associated with luminal-and basal-like breast cancer
Based on gene expression signatures, breast carcinomas have recently been classified into subgroups resembling Figure 5 The HRE-lacking AREG promoter chromatin is occupied by HIF-2a. (a) Sequence similarity of the AREG promoter in 15 different species harboring a 100% conserved TATAAA box (lower panel). Conserved elements of at least 3 bp with 490% sequence similarity were mutated as indicated in the upper scheme of the reporter construct. (b) Mutated and 3 0 -truncated (SacI and SmaI, respectively) AREG reporter constructs were co-transfected with HIF-a expression plasmids and an empty vector as before. The data are shown as responsiveness to HIF-a isoforms normalized to the empty expression vector, derived from three independent transfections analyzed in triplicates. The asterisks indicate significant differences between the HIF-1a and HIF-2a responsiveness of the respective constructs (Tukey's multiple comparison test; **Po0.01). (c) HIF-1a and HIF-2a binding to the human AREG and BHLHB2 promoters. ChIP assays were performed on parental MCF-7 cells exposed to 20 or 1% oxygen for 4 and 24 h. DNA/protein complexes were immunoprecipitated by using HIF-a-specific antibodies or normal rabbit serum as control. Enrichment of AREG and BHLHB2 promoter chromatin in immunoprecipitates and input DNA was analyzed by quantitative PCR. The upper panels show the agarose gels of a representative ChIP experiment, whereas quantifications of three independent biological repeats analyzed by qChIP are shown in the lower panels (mean ± s.e.m.). (d) A schematic representation of HIF-a hybrid expression constructs with interchanged N-terminal protein portions. (e-h) Dual luciferase analyses using the human AREG, WISP2 and PHD2 promoter reporter constructs or a concatemerized HRE in conjunction with an SV40 promoter-driven luciferase (pH3SVL). MCF-7 parental cells were cotransfected with reporter genes and HIF-a expression plasmids or an empty vector. A representative experiment performed in triplicates is shown (mean±s.e.m.). The phosphorylation levels of the EGFR family were quantified from at least three independent cultures. The asterisks indicate significant differences of the mean as determined by unpaired Student's t-tests (*Po0.05; ***Po0.001). (b) Recombinant AREG activates EGFRs and ErbB4 receptors in shHIF2A-knockdown cells. MCF-7 shHIF2A cells were grown at 0.1% FCS for 20 h and stimulated with recombinant AREG (100 ng/ml) for up to 20 min. The phosphorylation levels of EGFR family members were quantified from three independent experiments. The strongest phosphorylation levels in each experiment were set as 1.0 and data are given as mean±s.e.m.
HIF-2a is associated with luminal breast cancer DP Stiehl et al their suggested origination from basal-like (estrogen receptor (ESR)-negative) or ESR-positive, luminal mammary epithelial cells (Perou et al., 2000) . Similar transcriptional characteristics were obtained for more than 50 widely used breast cancer cell lines, subsequently categorized according to their gene cluster segregation as basal-A, basal-B or luminal cell models (Neve et al., 2006; Kao et al., 2009) . As EGFR has been established as a marker gene of basal epithelial cells (Nielsen et al., 2004) , we wondered whether the AREG-EGFR/ErbB4 autocrine loop is associated with one particular subtype of breast carcinomas.
Expression data for the HIF-a-predictive genes identified in our study (AREG, PAI1, CA9 and GLUT1) as well as the EGFR family members (EGFR, ErbB2, ErbB3 and ErbB4), and the respective luminal (ESR1) and basal (KRT5) marker genes, were extracted from a data set, which previously identified 8750 variably expressed genes from 50 breast cancer cell lines (Kao et al., 2009 ). WISP2 was not among the genes listed. As shown in Figure 7a , AREG was highly expressed specifically in ESR1-positive luminal cell types, cosegregating with high transcript levels of ErbB3 and ErbB4, but with low expression of EGFR. A second HIF-2a is associated with luminal breast cancer DP Stiehl et al cluster with high AREG transcript levels included cell lines with low expression of ESR1 derived from nontumorigenic mammary tissue (MCF-10A, 184A1 and hTERT-HME1) and EGFR-overexpressing SUM149 and SUM102 cell lines, both showing low levels of the other ErbB family member. As expected, EGFR expression was specifically high in basal-like cell types, possibly indicating a leading role of ErbB4 in mediating the autocrine effects of AREG in luminal cancers. Interestingly, the T47-D and BT474 cell lines clustering very close to MCF-7 cells in the cell line meta-analysis (Figure 7a ) also showed a tendency toward an HIF-2a-dominated response in chronic hypoxia, although HIF2a expression was relatively low in BT474 (Figure 7b ). By contrast, both HIF-a isoforms were transiently expressed in ZR75-1 cells which showed low basal AREG expression and a more disparate gene signature (Figures 7a and b) . A highly significant correlation (Po0.01, Spearman's r) between HIF-2a/AREG/WISP2 and proteins indicating luminal epithelial differentiation (ESR and progesterone receptor, respectively) was confirmed by immunohistochemistry in our cohort of 282 breast cancer patients. Reciprocally, HIF-1a as well as PAI1 and GLUT1 were significantly associated with expression of the basal cytokeratin KRT5 (Po0.01-0.05), suggesting a dominant role of HIF-1a in basal-like tumors (Figure 7c ). In line with a luminal signature, AREG and WISP2 were found to be highly expressed in luminal cells of healthy mammary tissue (Figure 7d) . The retaining activity of the HIF-2a-specific pathway thus could be indicative of a higher degree of tumor cell differentiation, which is further supported by the fact that HIF-2a-dependent AREG and WISP2 expression was negatively correlated with tumor grading (Spearman's r, À0.169, Po0.01; and À0.233, Po0.01, respectively).
Discussion
Genome-wide promoter tiling arrays identified a common 5 0 -RCGTG-3 0 binding motif for both HIF-1 and HIF-2, which is identical to our previously published consensus core HRE defined by 470 characterized HIF target genes (Wenger et al., 2005; Mole et al., 2009) . Remarkably, 15% of the HIF-2 (and even 30% of the HIF-1)-binding regions identified in the same study did not contain any consensus 5 0 -RCGTG-3 0 motif (Mole et al., 2009) , calling for alternative modes of HIF-DNA interaction. The HIF-2a-responsive AREG promoter described in this study represents an example of such an HRE-independent gene regulation, and ChIP data confirmed physical interaction of HIF-2a with the promoter region of human AREG. Target gene specificity in this case likely arises from additional trans-acting factors and/or cis-regulatory elements that cooperate specifically with HIF-2a. In a variety of HIF-2a-selective promoters (including the WISP2 promoter) HREs have previously been reported to cooperate with ETS-family transcription factor-binding sites (Elvert et al., 2003; Aprelikova et al., 2006; Hu et al., 2007; Le Bras et al., 2007; Wang et al., 2010) , and HIF-2a has been shown to physically interact with ETS-1 and ELK-1 (Elvert et al., 2003; Aprelikova et al., 2006) . Other HIF-2a-regulated genes at least contained one consensus HRE (Covello et al., 2006; Yamashita et al., 2008; Yang et al., 2010) , although the stringency with which the core HRE has been determined was sometimes lowered to only half-sites of the 5 0 -RCGTG-3 0 motif (Saito et al., 2010) . Notably, no ETS-binding 5 0 -GGA(A/T)-3 0 core motif is present in the minimal HIF-2a-responsive AREG promoter region, suggesting the existence of a so far unrecognized pathway.
By phylogenetic and subsequent mutational analysis of the minimal AREG promoter, we identified a conserved WRE, mediating the HIF-2a-specific activation of AREG expression in MCF-7 breast cancer cells. Previous work identified the WT-1(ÀKTS) splice variant as a potent transcriptional activator binding to this particular site (Lee et al., 1999) . We could not detect any expression of WT-1 mRNA in MCF-7 cells, which is in line with a previous study on the expression and epigenetic regulation of WT-1 in human breast cancers (Loeb et al., 2001) . Thus, a so far undefined WREbinding activity is likely to mediate AREG expression in response to HIF-2a. While the HIF-2a-dependent enrichment of the AREG promoter in ChIP experiments reveals direct recruitment of the transcription factor to the larger regulatory region, it remains unclear if direct DNA binding of HIF-2a to the WRE is involved. HIF2a ChIP experiments showed hypoxically induced chromatin enrichment of the known WRE-dependent heparin-binding EGF-like growth factor (HBEGF) gene, which had been identified in a genome-wide screen for novel WT-1 targets along with AREG (Kim et al., 2007) , suggesting that the HIF-2a/WRE interplay might involve a more general mechanism (DPS and RHW, unpublished data) .
Evidence supporting a model of a shared HIF-2a/ AREG/WISP2 pathway arises from clinical data of 282 breast cancer patients, where a strikingly good correlation of either growth factor specifically with HIF-2a was observed. Only patients with high levels of both AREG and WISP2 showed similarly prolonged survival times like the HIF-2a-positive cohort, indicating a concerted action of these proteins. Contrary to our results, another study found HIF-2a associated with distant recurrence and poor outcome in invasive breast cancer (Helczynska et al., 2008) . HIF-2a antibody specificity has been validated in both studies and hence is unlikely to explain the discrepancy. In agreement with our data showing significant correlation of HIF-1a expression with disseminated disease stages, conditional deletion of HIF-1a in the mammary epithelium of mice expressing the PyMT oncoprotein resulted in retarded tumor growth and decreased pulmonary metastasis (Liao et al., 2007) .
HIF-2a has been discussed as a critical mediator of renal tumorigenesis by enhancing c-Myc activity in vivo, particularly in renal cell carcinoma exclusively expressing this isoform, and overexpression of HIF-2a increased xenografted tumor growth (Raval et al., 2005; Gordan et al., 2007 Gordan et al., , 2008 . However, we did not observe any changes in c-Myc-dependent transcription in MCF-7 cells preferentially expressing HIF-2a (Supplementary Figure S5) , implying that the HIF-2a/c-Myc interplay probably is tissue-specific. Surprisingly, stabilized HIF2a mutants promoted the growth of xenografted renal cell carcinoma cell tumors and Kras
G12D
-driven lung tumorigenesis in mice (Yan et al., 2007; Kim et al., 2009) , whereas Hif2a deletion in the same lung cancer model likewise increased tumor burden (Mazumdar et al., 2010) . Although contradictory at first sight, Mazumdar et al. (2010) propose a model where forced expression of HIF-2a enhances tumor growth by activation of tumor-promoting target genes, whereas genetic silencing of HIF-2a leads to loss of tumorsuppressor genes also boosting tumorigenesis.
What could be the mechanism behind such a dual role of transcriptional regulation by a single factor? Interestingly, we identified two distinct groups of HIF-2-regulated genes: one set was particularly upregulated by HIF-2a in the absence of HIF-1a, but still responding to hypoxia in an HIF-1a-dependent manner, whereas another set was exclusively restricted to HIF-2a. Therefore, HIF-2a could act bi-directionally through a canonical HRE-mediated pathway overlapping with HIF-1a, plus an HRE-independent, HIF-2a-specific mechanism.
Intriguingly, all genes that clustered in the HIF-2a-affected groups were either transmembrane (ITPR1, EGFR) and/or secreted proteins (IGFBP3, LOXL2, PAI1, WISP2, AREG), suggesting a novel role of HIF-2a in regulating intercellular communication. Supporting this hypothesis, EGFR and ErbB4 receptor activation was significantly lower in the absence of HIF2a, and exactly those two receptors were predominantly activated by AREG. To the best of our knowledge, AREG establishes the first direct link between HIF-2a-dependent transcription and EGFR family activation in human breast cancers. Moreover, we found a strong correlation of HIF-2a, AREG and WISP2 protein levels in tumor samples with luminal differentiation, providing evidence that the HIF-2a-specific transcriptional pathway could have an important role in maintaining a noninvasive phenotype, as it has been reported for tumors expressing WISP2 before (Banerjee et al., 2008; Fritah et al., 2008) .
Growth of MCF-7 cells depleted of HIF-2a was impaired under oxygen and nutrient-limiting conditions in vitro, but a negative correlation of HIF-2a with tumor size and grade was observed in clinical samples. Such disparate proliferation characteristics of cells cultured in vitro or grown as xenografts in vivo have been described previously for A549 lung carcinoma cells with reduced levels of HIF-2a (Franovic et al., 2009; Mazumdar et al., 2010) . Cancer cells interact with the surrounding microenvironment by secretion of a variety of growth factors, partially mediated by an HIF-2a-specific transcriptional pathway. In normoxia, a balanced activation of canonical and HIF-2-specific pathways tightly controls energy homeostasis and cellular proliferation (Figure 8a ). Tumor cells, however, encounter periods of severe oxygen starvation, ultimately selecting for phenotypes resistant to a hostile environment (Gatenby et al., 2007) . Thus, cancer cells expressing high levels of HIF-2a (like those cells with suppressed HIF-1a in our study) might benefit from increased autocrine and paracrine growth factor signaling, supporting cellular autonomy by masking unfavorable growth conditions. As a consequence, selection pressure in these cancers might be reduced and tumor progression is slowed down (Figure 8b ). On the other hand, cells predominantly expressing HIF-1a recruit oxygen-independent energy pathways but may suffer from decreased mitogenic signaling owing to loss of HIF-2a-specific growth factors. Increased selection pressure forcefully promotes growth factor-independent tumorigenesis, eventually leading to the acquisition of invasive properties and dissemination of the disease (Figure 8c) . In clinical practice, cytotoxic therapies are largely ineffective on cells within the most inhospitable environments, often leading to relapse of the disease after an initial phase of tumor mass reduction. Based on the recently developed concepts of 'adaptive therapy', where a stable tumor burden of higher differentiated tumor cells is sustained to suppress the growth of slowproliferating but therapy-resistant phenotypes (Gatenby et al., 2009) , novel therapies maintaining an HIF-2a-dominated phenotype could prove of value to treat breast cancer.
Materials and methods

Cell culture and derivatives
All human breast cancer cell lines were cultured in Dulbecco's modified Eagle's medium (high glucose; SigmaAldrich, St Louis, MO, USA) supplemented with 10% FCS, 50 IU/ml penicillin and 50 mg/ml streptomycin (Invitrogen, Carlsbad, CA, USA). Generation of MCF-7 cell lines with stable HIF-a suppression is described in detail under Supplementary Materials and methods. Hypoxia kinetics were performed at 1% oxygen and 5% CO 2 in a gascontrolled glove box (InvivO2 400; Ruskinn Technologies, Bridgend, UK).
Tissue specimen and tissue microarray analysis Histopathological and immunohistochemical analyses of tumor tissues from 282 invasive breast cancer cases diagnosed at the Institute of Surgical Pathology (University Hospital, Zu¨rich, Switzerland) were performed essentially as described by Bordoli et al. (2011) . Appropriate review board consent has been obtained to allow the use of these materials for research purposes. The antibodies used for immunohistochemistry are listed under Supplementary Materials and methods.
Human phospho-RTK array
The phosphorylation status of 16 RTKs has been assessed in parallel by using Proteome Profiler 96 (R&D Systems, Minneapolis, MN, USA). Briefly, 1 Â 10 6 MCF-7 cells or derivatives were grown in 0.1% FCS for 20 h and stimulated with recombinant AREG (100 ng/ml; R&D Systems), WISP2 (100 ng/ml; Creative Biomart, Shirley, NY, USA) or 10% FCS for up to 20 min. Cells were lysed immediately and protein concentration was determined by the Bradford method. Cellular protein (1-25 mg) was subjected to the provided twosite sandwich ELISA plate and the assay was performed by following the manufacturer's instructions. Signals were detected by using a luminescent image analyzer (LAS-4000; FUJIFILM, Tokyo, Japan) and spot intensities were quantified by using the Quantity One software package (Bio-Rad, Hercules, CA, USA).
Chromatin immunoprecipitation
ChIP assays of parental MCF-7 cells exposed to 20 or 1% O 2 for 4 and 24 h have been performed essentially as described previously (Holmquist-Mengelbier et al., 2006) . The following antibodies and antisera were used for immunoprecipitation: rabbit polyclonal anti-HIF-1a whole antiserum (ab2185; Abcam, Cambridge, UK) and rabbit polyclonal anti-HIF-2a IgG fraction (ab199; Abcam). Normal rabbit serum (code 011-000-001; Jackson ImmunoResearch, West Grove, PA, USA) served as unspecific control. Enrichment of AREG and BHLHB2 promoter chromatin was determined by quantitative PCR using the following oligonucleotides: AREG forward 5 0 -TTTTCGGGTAGCACCTTCTG-3 0 and AREG reverse 5 0 -GC ACCTGCCGCTTTATAGG-3 0 ; BHLHB2 forward 5 0 -GCCT GGAGTCACAGGGTAGA-3 0 and BHLHB2 reverse 5 0 -CA AGCCGAGGAGTAATGGAG-3 0 .
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